nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cdk5 as a drug target for the treatment of Alzheimer’s disease
|
Lau, Lit-Fui |
|
2002 |
19 |
3 |
p. 267-273 |
artikel |
2 |
Cellular models for tau filament assembly
|
Ko, Li-wen |
|
2002 |
19 |
3 |
p. 309-316 |
artikel |
3 |
Discovery of compounds that will prevent tau pathology
|
Kosik, Kenneth S. |
|
2002 |
19 |
3 |
p. 261-266 |
artikel |
4 |
In vivo brain imaging of tangle burden in humans
|
Small, Gary W. |
|
2002 |
19 |
3 |
p. 321-327 |
artikel |
5 |
Neurofibrillary degeneration can be arrested in an in vivo cellular model of human tauopathy by application of a compound which inhibits tau filament formation in vitro
|
Hall, Garth F. |
|
2002 |
19 |
3 |
p. 251-260 |
artikel |
6 |
Neuroprotective properties of valproate
|
Loy, Rebekah |
|
2002 |
19 |
3 |
p. 301-307 |
artikel |
7 |
Organotypic slice cultures from transgenic mice as disease model systems
|
Duff, Karen |
|
2002 |
19 |
3 |
p. 317-320 |
artikel |
8 |
Pin1
|
Hamdane, Malika |
|
2002 |
19 |
3 |
p. 275-287 |
artikel |
9 |
p38 mitogen activated protein kinase as a therapeutic target for Alzheimer’s disease
|
Dalrymple, Stacie A. |
|
2002 |
19 |
3 |
p. 295-299 |
artikel |
10 |
Tau and Alzheimer’s disease
|
Fillit, Howard M. |
|
2002 |
19 |
3 |
p. 249-250 |
artikel |
11 |
Tau as a drug target in Alzheimer’s disease
|
Gozes, Illana |
|
2002 |
19 |
3 |
p. 337-338 |
artikel |
12 |
Tau neurofibrillary pathology and microtubule stability
|
Michaelis, Mary L. |
|
2002 |
19 |
3 |
p. 289-293 |
artikel |
13 |
Tau therapeutics for alzheimer’s disease
|
Gold, Michael |
|
2002 |
19 |
3 |
p. 329-334 |
artikel |